223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study

Xianjun Yu, Lin Shen, Jin Hao, L. Wang, Hongming Pan, Guohong Han, Jianming Xu, Y. Zhang, S. Yang, Jieer Ying, Muye Li, Damir Begic, Bing Lu, Rui XuAnnals 2015 · DOI

BibTeX
@article{yu2015p,
  author = {Xianjun Yu and Lin Shen and Jin Hao and L. Wang and Hongming Pan and Guohong Han and Jianming Xu and Y. Zhang and S. Yang and Jieer Ying and Muye Li and Damir Begic and Bing Lu and Rui Xu},
  title = {{223P Efficacy and safety of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in Chinese patients (Pts) with metastatic adenocarcinoma of the pancreas (MPC): A phase II study}},
  journal = {Annals},
  year = {2015},
  doi = {10.1093/annonc/mdv523.84},
}

Loading related content...

Figure